UK GOVERNMENT: “EXPECT HIGH VOLUME OF COVID-19 VACCINE ADVERSE DRUG REACTION”.

UK Government’s Medicines & Healthcare products Regulatory Agency (MHRA) intends to spend £1.5 million on an Artificial Intelligence to monitor the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs). If this isn’t alarming, I don’t know what is.

"The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed".

The tender is here . . .